Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 18 Jan 2024 for Acutus Medical, Inc.. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
David Roman: trading record in brief
David Roman (finance chief) discloses dealings in Acutus Medical, Inc. to SEC (Form 4). In total, 10 filings cover trades dated from 1 February 2022 to 7 January 2024.
The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
On 18 January 2024 came the latest disclosure, a share grant in Acutus Medical, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to David Roman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations10 total
24,086 shares@ €0.172610.1% of flowForm 4SEC:0001628280-24-001668:0
6,484 shares0FORM 4SEC:0001628280-23-026911:0
17,290 shares@ €0.78833.0% of flowFORM 4SEC:0001628280-23-020587:0
3,165 shares@ US$0.7545.3% of flowFORM 4SEC:0001628280-23-010611:0
135,000 shares0FORM 4SEC:0001628280-23-006079:0
10,196 shares@ €1.721842.5% of flowFORM 4SEC:0001628280-23-002079:0
75,000 shares0Common StockSEC:0000950103-22-013449:0
100,000 shares0Common StockSEC:0000950103-22-009981:0
3,248 shares@ €1.1741100.0% of flowCommon StockSEC:0000950103-22-006020:0
50,000 shares0Common StockSEC:0000950103-22-002001:0
10 of 10 declarations
